Retrotransposon LINE‐1 Activation Drives Microglial Dysregulation in Late‐Onset Alzheimer's Disease
Our findings suggest that LINE-1 activation drives microglial dysregulation, contributing to neuroinflammation and cellular dysfunction in LOAD. These data identify LINE-1 as a novel mechanism of microglial impairment and position it as a potential therapeutic target for mitigating neuroinflammatory processes in Alzheimer's disease.
Authors
- Falak Sher
Institutions
- Earth Island Institute (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_102972
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00